These findings for significant reductions in overall and nocturnal hypoglycaemia lend further support to previous findings for improved hypoglycaemia with flash technology utilisation in diabetes treated with intensive insulin therapy [13, 33]. This evidence concerns the gene INS and diabetes mellitus.